Research Article
Increased Levels of Granulocytic Myeloid-Derived Suppressor Cells in Peripheral Blood and Tumour Tissue of Pancreatic Cancer Patients
Table 1
Characteristic features of study subpopulations.
| | | PC | CP | HDs |
| | Number | | | | | Age (median) | 64.5 (41–85)* | 49 (23–72)* | 51 (24–89)* | | Gender (male : female) | 13 : 11 | 5 : 7 | 7 : 9 | | TNM stage | | | | | I | 0 | — | — | | II | 6 | — | — | | III | 1 | — | — | | IV | 17 | — | — | | Tumour size (cm) | 3.2 (1.9–6.1)* | | | | Preoperative CA19-9 (0–37 U/mL) | 399 (77–1230)* | 54 | — | | Preoperative CEA (<2.5 ng/mL) | 5 (5–13)* | — | — | | Tumour site | | | | | Head of pancreas | 18 | — | — | | Body of pancreas | 2 | — | — | | Tail of pancreas | 4 | — | — | | Histological grade | | | | | Well/moderate | 6 | — | — | | Poor/undifferentiated | 18 | — | — |
|
|
PC: pancreatic cancer; CP: chronic pancreatitis; HDs: healthy donors; CA19-9: cancer antigen 19-9; CEA: carcinoembryonic antigen.Data shown represent median (range).
|
